Streetbeat News

Earnings

CNHI

CNH Industrial has projected its net sales to increase by 3-5% in 2023. However, the company's adjusted EPS target is about $1.70, lower than the estimated $1.75.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:33 pm

BOWL

Bowlero (NYSE:BOWL) reported Q1 sales of $227.41 million, missing the analyst consensus estimate of $229.91 million by 1.09 percent. This represents a 1.24 percent decrease from the same period last year. However, the company reported a net income of $18.2 million, a significant improvement from a loss of $33.5 million YoY.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:33 pm

CNHI

CNH Industrial (NYSE:CNHI) reported Q3 earnings of $0.42 per share, beating the analyst consensus estimate of $0.41 by 2.44%. However, the company's quarterly sales of $5.99 billion missed the analyst consensus estimate of $6.06 billion by 1.14%.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:32 pm

BCO

Brink's reported Q3 2023 earnings per share (EPS) of $1.92, beating the estimate of $1.79. The company's revenue of $1.227 billion also surpassed the estimate of $1.226 billion.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:32 pm

STIM

Neuronetics has reported that it shipped 43 NeuroStar Systems in the third quarter.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:32 pm

IMXI

IntL Money Express (NASDAQ:IMXI) reported Q3 adjusted earnings of $0.51 per share, beating the analyst consensus estimate of $0.50 by 2 percent. This is a 5.56 percent decrease from the same period last year. The company also reported quarterly sales of $172.44 million, beating the analyst consensus estimate of $170.65 million by 1.05 percent, a 22.50 percent increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:32 pm

SGRY

Surgery Partners reported Q3 adjusted earnings of $0.19 per share, beating the analyst consensus estimate of $0.16 by 18.75%. This is a 1050% increase over losses from the same period last year. The company also reported quarterly sales of $674.10 million, beating the analyst consensus estimate of $672.27 million by 0.27%. This is an 8.62% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:32 pm

STIM

Neuronetics reported Q3 losses of $(0.33) per share, missing the analyst consensus estimate of $(0.31) by 6.45 percent. This is a 17.86 percent decrease over losses from the same period last year. However, the company's quarterly sales of $17.88 million beat the analyst consensus estimate of $17.58 million by 1.73 percent, marking an 8.40 percent increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:31 pm

NYAX

Nayax (NASDAQ:NYAX) reported Q3 losses of $(0.09) per share, a 69% improvement from $(0.30) per share YoY. The company's sales also increased by 27.68% to $60.33 million from $47.25 million YoY.

Portfolio Pulse from bharat@benzinga.com

November 07, 2023 | 12:31 pm

AHCO

AdaptHealth has revised its FY23 net revenue guidance to $3.16B-$3.185B, slightly lower than its previous guidance of $3.16B-$3.2B and consensus of $3.17B. The company also lowered its adjusted EBITDA guidance to $630M-$650M from the previous $650M-$680M.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 12:30 pm